论文信息 - A phase I study of MDM2 antagonist RG7112 in patients (pts) with relapsed/refractory solid tumors. - 字舞流文

A phase I study of MDM2 antagonist RG7112 in patients (pts) with relapsed/refractory solid tumors.

J. Blay | L. Vassilev | R. Kurzrock | R. Maki | G. Schwartz | A. Patnaik | J. Zhi | S. Middleton | B. Nguyen | D. Geho | L. Gore | A. Wagner | Lin Wu | G. Nichols | M. Ding